Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Relation Between Attentional, Sensory and Emotional Dysregulation in Adults With Posttraumatic Stress Disorder: a Double-blind, Placebo-controlled Randomized Controlled Trial of the Combined Treatment With Reboxetine and Methylphenidate

NCT05133804 is registered in ClinicalTrials.gov with University of Haifa as lead sponsor.

NCT NCT05133804
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05133804 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Relation Between Attentional, Sensory and Emotional Dysregulation in Adults With Posttraumatic Stress Disorder: a Double-blind, Placebo-controlled Randomized Controlled Trial of the Combined Treatment With Reboxetine and Methylphenidate
Lead sponsor
University of Haifa
Phase
Phase 2
Overall status
Recruiting
Start date
June 1, 2022
Completion date
December 1, 2026
Enrollment
53 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

posttraumatic stress disorder